Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Make a note!

$PolyPid (PYPD.US)$ Approximately 250 Patients of a Planned Total of 600 Subjects Currently Enrolled in SHIELD II
Unblinded Interim Analysis to be Conducted Once Approximately 400 PatientsComplete Their 30-Day Follow-up; Top-line Results Expected in the First Quarter of 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3322 Views
Comment
Sign in to post a comment